CLINICAL BLOG  |  INTEGRATIVE MEDICINE

Parallel Worlds of Healing: Chinese Medicine’s Spleen and Kidney Schools Meet Functional Medicine

Yoon Hang “John” Kim, MD, MPH

Board-Certified, Preventive Medicine and Integrative/Holistic Medicine  •  Direct Integrative Care

1. Two Systems, One Vision of Health

After more than two decades practicing integrative medicine — and a fellowship in medical acupuncture at UCLA — I have come to view Traditional Chinese Medicine (TCM) and Functional Medicine not as competing paradigms, but as parallel descriptions of the same physiology, written in different languages. Where the ancient texts speak of Spleen Qi and Kidney Essence, the modern bench speaks of microbial diversity, intestinal barrier integrity, hypothalamic–pituitary–adrenal (HPA) regulation, and mitochondrial bioenergetics. The vocabularies differ; the territory is the same.

This convergence is not metaphor. A growing body of mechanistic and clinical literature demonstrates that the TCM Spleen school — centered on digestion, transformation, and the production of “acquired Qi” — maps with striking fidelity onto the gut–microbiome–immune axis. The TCM Kidney school — governing constitutional vitality, reproduction, and aging — maps onto the neuroendocrine–mitochondrial network. Recognizing these parallels gives the modern integrative clinician two complementary, evidence-informed lenses with which to evaluate the same patient.

2. The Spleen School: Digestive Optimization in Chinese Medicine

2.1 What the “Spleen” Means in TCM

In Chinese medical theory, the Pí (脾, conventionally translated as “Spleen”) is a functional system, not the anatomic organ. It encompasses digestion, nutrient transformation, fluid metabolism, and immunity, and its work is paired with the Stomach. Modern TCM scholars describe the Spleen as a composite of pancreatic, splenic, and lymphoid functions — “the hub of digesting food, distributing the food essence, and body fluid metabolism” ¹. The Spleen produces postnatal Qi — the daily, replenishable energy generated from food and breath — in contrast to the inherited Kidney Essence present at birth.

2.2 Spleen Syndromes in the Functional-Medicine Patient

The two Spleen patterns most often encountered in a functional-medicine practice are Spleen Qi deficiency and Spleen-with-Dampness. Spleen Qi deficiency presents as fatigue, postprandial bloating, loose stools, food cravings, easy weight gain, and a pale, scalloped tongue. The Damp-phlegm picture overlaps strikingly with what we now diagnose as small intestinal bacterial overgrowth (SIBO), bile acid diarrhea, post-infectious irritable bowel syndrome, and food-sensitivity–driven brain fog. Clinically, recognizing these patterns gives me a framework for sequencing therapy when laboratory data are still pending.

2.3 The Microbial Signature of “Spleen Deficiency”

What was once a clinical pattern is now a measurable phenotype. Lin and colleagues, using LC–QTOFMS metabolomics combined with 16s rRNA sequencing, demonstrated that patients meeting the Chinese-medicine criteria for Spleen-yang-deficiency syndrome (SYDS) have a distinct gut-microbial signature and altered host metabolism, with significant shifts in Lachnospiraceae, Bacteroides, and bile-acid handling ². Earlier work in spleen-deficient mouse models had shown reductions in Lactobacillus and Bifidobacterium that were reversed by classical Spleen-tonifying decoctions such as Sijunzi Tang ³.

More recent work continues to extend the picture. In an IBS-D rat model with induced Spleen-deficiency syndrome, both fecal microbiota transplantation and the classical formula Shenling Baizhu San improved the gut-barrier proteins occludin-1 and claudin-1 and modulated dysbiosis-associated metabolic pathways ⁴. A 2023 study using a compound TCM formula (F1) for spleen-deficiency diarrhea found that the formula simultaneously regenerated intestinal villi and increased serum short-chain fatty acid (SCFA) levels ⁴ˢ. Ginseng — the prototypical Spleen-Qi tonic — has been shown to elevate beneficial genera and propionate concentrations in spleen-Qi-deficient rats ⁵. A 2026 review in Frontiers in Pharmacology synthesizes the data to argue, plausibly, that the TCM principle of “strengthening the spleen and dispelling dampness” is mechanistically a microbial strategy in obesity and metabolic disease ⁶.

Two clinical takeaways follow. First, Spleen-deficiency is not a vague pre-scientific construct — it has reproducible biological correlates in the stool and on the metabolome. Second, the Spleen-tonifying herbs are, in effect, prebiotic and barrier-restoring agents whose mechanism the West has only recently begun to characterize.

3. The Functional-Medicine Gut Paradigm

Functional medicine arrived at the gut from a different direction — epidemiology, mucosal immunology, and microbiome science — but the clinical destination is the same. The contemporary model treats the gastrointestinal tract as the principal site of postnatal health: a 150:1 microbe-to-host gene ratio, a daily output of vitamins and short-chain fatty acids, an immune surface that schools the systemic immune system, and an enteric nervous system that communicates bidirectionally with the brain through vagal, endocrine, and microbial-metabolite pathways ⁷.

When that ecosystem is disrupted — by antibiotics, ultra-processed food, glyphosate exposure, chronic stress, or shift work — the downstream consequences include increased intestinal permeability, low-grade systemic inflammation, immune dysregulation, hormonal disruption, and neuropsychiatric symptoms. Umeda has explicitly framed this as a Western description of what the TCM tradition has called Spleen-Qi deficiency for centuries ⁸. In a similar vein, an integrative review in Explore by Greenfield and colleagues drew direct lines from “dysbiosis, Spleen Qi, phlegm, and complex difficulties,” arguing that strengthening the Spleen — by warming, drying, and supporting the digestive interface — is essentially a clinical strategy for restoring microbial balance ⁹.

Functional-medicine tools for assessing the gut are now well established: comprehensive stool analysis with culture-independent sequencing, hydrogen and methane breath testing for SIBO, organic-acid testing for fungal overgrowth and mitochondrial cofactor sufficiency, food-sensitivity panels (interpreted cautiously), and zonulin or related markers of barrier function. Therapy follows a familiar structure — sometimes shorthanded as “5R” (Remove, Replace, Reinoculate, Repair, Rebalance) — and frequently uses zinc carnosine, L-glutamine, mucilage botanicals, multi-strain probiotics, prebiotic fibers, and targeted antimicrobials when indicated.

4. Digestive Optimization: Integrating Spleen and Functional-Medicine Approaches

4.1 Diet at the Intersection

My clinical practice merges the two systems at the dinner table. The Spleen tradition argues for warm, cooked, easily digested foods, particularly during the cold months and in patients who are depleted. The functional-medicine tradition argues for personalized elimination strategies (low-FODMAP, autoimmune-protocol, specific carbohydrate diet) tailored to lab data. These are not opposed. A low-FODMAP plan executed with congees, broths, ginger, and warming spices is more sustainable — and often more effective — than the same plan executed with raw salads and cold smoothies.

4.2 Circadian Alignment as a Spleen-Friendly Practice

Both systems converge on meal timing. The Chinese organ clock places peak digestive function in the morning hours — Stomach (7–9 AM) and Spleen (9–11 AM) — advising that the largest meal be taken early. Modern chronobiology agrees: time-restricted eating (TRE) within a 10–12-hour window aligned with daylight increases gut microbial diversity, upregulates the circadian clock genes Bmal1 and Clock, and improves lipid and glucose metabolism ¹⁰. Animal models demonstrate that time-restricted feeding partially restores the cyclical fluctuations of the gut microbiota and protects against diet-induced metabolic disease ¹¹. Early-window TRE (eating from approximately 8 AM to 4 PM) appears more effective than late-window TRE for both microbial alpha-diversity and cardiometabolic markers ¹² — a striking modern echo of the Spleen-clock teaching.

4.3 Acupuncture and Herbs as Adjuncts

Where labs guide remove/replace decisions, acupuncture and Spleen-tonifying herbs can be layered on for symptom relief and mucosal repair. A 2024 umbrella review in the Journal of Integrative Medicine analyzed 15 systematic reviews of acupuncture and moxibustion for IBS, finding evidence — of mixed but generally favorable quality — for benefit on symptom severity, abdominal pain, and quality of life ¹³. An earlier high-quality meta-analysis in the American Journal of Gastroenterology (2012) found that, while acupuncture did not outperform sham acupuncture in pooled blinded trials, it was superior to standard pharmacotherapy and to no-treatment controls ¹⁴. A 2024 multicenter, sham-controlled RCT in Frontiers of Medicine demonstrated a 140-point reduction in IBS-SSS at four weeks with real acupuncture versus 64-points with sham (P < 0.001) in patients with refractory IBS ¹⁵. The evidence for acupuncture as a stand-alone IBS therapy is therefore best characterized as promising and clinically useful, though not yet definitive in the placebo-controlled sense.

5. The Kidney School: Vitality, Mitochondria, and Hormones

5.1 The Kidneys as the Root of Constitutional Vitality

If the Spleen is the engine of daily energy, the Kidneys hold the deeper reserve. In Chinese medicine the Kidneys store Jing (Essence), govern bones and marrow, control reproduction, and underwrite long-term resilience. Aging itself is conceptualized as the gradual exhaustion of Kidney Essence. Symptoms of Kidney depletion — chronic fatigue, low libido, low back and knee pain, cold intolerance, slow recovery, hair loss, osteopenia, hearing changes — read like a textbook of HPA-axis depletion and andropause/menopause.

5.2 Kidney-Yang Deficiency Maps onto HPA Dysregulation

Half a century of bench research, summarized by the influential Chinese physiologist Zi-yin Shen, has progressively located the substrate of Kidney-Yang deficiency syndrome (KYDS) in the hypothalamic–pituitary–adrenal axis and its connections to the thyroid and gonadal axes ¹⁶. The standard rodent model of KYDS — prolonged exogenous glucocorticoid administration followed by withdrawal — produces the classic clinical picture (cold extremities, exhaustion, decreased rectal temperature, hair loss, sexual dysfunction) together with measurable suppression of CRH, ACTH, cortisol, and 17-hydroxycorticosteroids, plus disordered HPT and HPG signaling ¹⁷.

Classical Kidney-Yang tonifying formulas reverse this state experimentally. Sini decoction restored circulating cortisol, ACTH, and testosterone in glucocorticoid-induced KYDS rats and upregulated NF-κB and CREB activity in adrenocortical H295R cells ¹⁸. Hirsutella sinensis (the artificial substitute for Cordyceps) attenuated KYDS in Lewis rats by normalizing ACTH, corticosterone, CRH, and immune-cytokine expression in the hypothalamus ¹⁹. Jinkui Shenqi pill — a 1,800-year-old prescription — prevented adrenal insufficiency during prednisone tapering in pediatric nephrotic syndrome, increasing the response rate from 65 % to 94 % at one year ²⁰. Epimedium (Yin Yang Huo), Rehmannia, and other Kidney botanicals show comparable HPA-restoring effects ²¹. The traditional clinical category of Kidney-Yang deficiency therefore corresponds, with reasonable fidelity, to what functional medicine often describes as “HPA-axis dysfunction” or “adrenal fatigue” — terms that, while imprecise, point at the same physiology.

5.3 The Kidney–Mitochondrial Parallel

The kidney organ itself is one of the most mitochondria-dense tissues in the body, and CKD is increasingly recognized as a mitochondrial disease at the cellular level ²². More striking, though, is that the Chinese-medicine concept of Yang — warmth, drive, oxidative metabolic activity — maps cleanly onto mitochondrial oxidative phosphorylation. Leong and colleagues, writing in Frontiers in Pharmacology, explicitly framed Yang/Qi-invigorating herbs as mitochondrial therapeutics, citing evidence that ginseng, schisandra, cordyceps, astragalus, and related botanicals stimulate mitochondrial biogenesis and ATP production while reducing oxidative stress in renal tissue ²³.

A 2025 mechanistic study made the parallel explicit. Investigators induced Spleen-and-Kidney-Yang deficiency in mice and found reduced Na⁺/K⁺-ATPase and Ca²⁺/Mg²⁺-ATPase activity, decreased lactase, intestinal microbial dysbiosis, and elevated TNF-α and IL-6, leading the authors to conclude that “the functions of kidney yang qi, spleen transportation, and mitochondrial energy metabolism are similar, as they all play a crucial role in maintaining normal physiological functions” ²⁴. This is, in essence, a Chinese-medicine restatement of the gut–mitochondria axis: the Spleen produces the substrate, the Kidney supplies the spark.

6. Functional Medicine Focus on Mitochondrial and Hormonal Health

Functional medicine reaches the same physiological territory through a different door. Mitochondrial dysfunction is now implicated in chronic fatigue, fibromyalgia, neurodegeneration, metabolic syndrome, and a substantial portion of post-viral and post-treatment syndromes. The clinical toolkit is broad: targeted nutrient repletion (CoQ10, PQQ, L-carnitine, magnesium, B-complex, alpha-lipoic acid), NAD⁺ precursor supplementation (nicotinamide riboside, NMN), light and cold exposure for mitochondrial biogenesis, and structured exercise.

Hormonal evaluation is similarly comprehensive: four-point salivary or urinary cortisol with DHEA, full thyroid panels (TSH, free T3, free T4, reverse T3, antibodies), sex-hormone profiling appropriate to life stage, and insulin–glucose dynamics. Treatment is rarely one-axis-at-a-time; a depleted HPA axis tends to drag thyroid output and gonadal steroidogenesis down with it, exactly as the TCM tradition predicts when it speaks of “Kidney Essence depletion.” Recognizing the Kidney pattern in a fatigued perimenopausal patient — cold, foggy, achy, sleeping poorly, libido absent — helps me pace the work, prioritizing sleep, glucose, and HPA repair before layering hormone replacement.

7. Integrative Vitality Protocols: Kidney–Mitochondrial–Hormonal Synergy

In practice, a Kidney-supportive integrative plan looks like the following — always individualized, never a kit:

First, sleep is non-negotiable. Circadian re-anchoring with morning sun exposure, late-evening dimming, a consistent bedtime, and no late-night eating is more powerful than any supplement. Second, stress regulation — breathwork, qigong, tai chi, vagal-tone practices — is treated as a clinical intervention rather than a lifestyle suggestion, because chronic sympathetic dominance is the engine of HPA depletion. Third, mitochondrial cofactors are matched to deficits identified on organic acid testing, with attention to magnesium, CoQ10, carnitine, and B-complex sufficiency. Fourth, Kidney-tonifying herbal formulas — used selectively, with attention to herb–drug interactions — may be layered on for patients with clear KYDS phenotypes. Fifth, hormonal support (thyroid, bioidentical hormone replacement, DHEA where indicated) is added only after the upstream pieces are in place.

This sequence reflects a clinical principle drawn from both traditions: heroic agents added to depleted soil do not work, and often worsen things.

8. Putting It Together: The Two-Axis Clinical Model

In my practice I now use a deliberate two-axis frame. The Spleen–gut axis comes first: digestion, microbiome, food sensitivities, barrier integrity, and the immune dysregulation that follows from their disorder. Once the gut is stable enough to absorb nutrients and to stop spilling endotoxin into circulation, the Kidney–mitochondrial–hormonal axis becomes both more accessible and more responsive. Adaptogens given to a leaky-gut patient often disappoint; given after the gut is repaired, they work.

Vignette 1: Chronic Fatigue with IBS

A 42-year-old woman with two-year history of fatigue, bloating, and loose stools, with confirmed methane-positive SIBO, presents on an unsuccessful low-FODMAP diet. From a TCM lens this is Spleen-Qi deficiency with Damp accumulation; from a functional-medicine lens, dysbiosis with barrier compromise. Treatment sequenced antimicrobial herbs with prokinetic and warming Spleen tonics (e.g., ginger, Atractylodes macrocephala–containing formulas, modified Sijunzi), bone-broth-based congee for the first ten days, glutamine and zinc carnosine for the barrier, and weekly acupuncture targeting Spleen-3, Stomach-36, and Conception Vessel–12. By six weeks, bloating, urgency, and afternoon fatigue had substantially improved — mirroring the published evidence for both Shenling-Baizhu-type formulas ⁴ and acupuncture for IBS ¹³ ¹⁵.

Vignette 2: Perimenopausal Fatigue with Brain Fog and Insomnia

A 49-year-old woman with insomnia, day-time fatigue, low libido, cold intolerance, and absent menses for nine months. Cortisol is flattened on four-point salivary testing; free T3 is low-normal; ferritin is low. From a TCM lens this is Kidney-Yang and Yin deficiency; from a functional-medicine lens, HPA-axis dysregulation with subclinical hypothyroidism. After establishing sleep-wake architecture, repleting iron, and stabilizing glucose, a Kidney-supportive plan including a Cordyceps/Hirsutella-type adaptogen ¹⁹, magnesium glycinate, methylated B-complex, and a low-dose bioidentical hormone trial produced clinically meaningful improvement in energy, sleep, and cognition.

9. Conclusion: Lenses, Not Camps

TCM and functional medicine are not competing systems; they are different vantage points on the same clinical reality. The Spleen ≈ gut–microbiome–immune axis. The Kidney ≈ HPA–thyroid–gonadal–mitochondrial network. Treating Spleen first and Kidney second is, in functional-medicine language, treating the gut first and the energetics-and-hormones layer second — a sequence supported by both two thousand years of clinical observation and an accelerating body of peer-reviewed mechanistic data. Used together, these lenses give the integrative clinician a richer, more humane framework than either provides alone, and they give the patient something rarer still: a description of their experience that is both ancient and rigorously modern. Luck favors the prepared bold.

References

1. Wu XN. Current concept of Spleen-Stomach theory and Spleen deficiency syndrome in TCM. World J Gastroenterol. 1998;4(1):2–6. PMID: 11819215.

2. Lin Z, Ye W, Zu X, et al. Integrative metabolic and microbial profiling on patients with Spleen-yang-deficiency syndrome. Sci Rep. 2018;8(1):6619. doi:10.1038/s41598-018-24130-7. PMID: 29700349.

3. Yan MZ. Influence of the Sijunzi decoction on the intestinal flora in a mice model with “spleen deficiency.” Zhongguo Weishengtai Xue Zazhi. 1987;1:203–243. (Foundational Chinese-language reference cited in: Liu R-X, Li Y, Zhang B. Human microbiome brings new insights to traditional Chinese medicine. J Bio-X Res. 2018;1(2):60–67.)

4. Yang Y, Wang B, Li T, Du J. FMT and TCM to treat diarrhoeal IBS with induced spleen deficiency syndrome — microbiomic and metabolomic insights. BMC Microbiol. 2024;24:436. doi:10.1186/s12866-024-03592-y.

4s. Yang B, Wang Y, Wang Z, et al. Compound Chinese medicine (F1) improves spleen-deficiency diarrhea by protecting the intestinal mucosa and regulating the intestinal flora. Front Microbiol. 2023;14:1292082. doi:10.3389/fmicb.2023.1292082. PMID: 38169801.

5. Zhang T, Li Q, Cheng L, Buch H, Zhang F. Effects of ginseng on short-chain fatty acids and intestinal microbiota in rats with spleen-qi deficiency based on GC-MS and 16s rRNA technology. Medicine (Baltimore). 2023;102(45):e35879. doi:10.1097/MD.0000000000035879. PMID: 37942687.

6. Wang R, et al. Gut microbiota and spleen-strengthening and dampness-dispelling therapies in obesity and related metabolic disorders: key mechanisms and therapeutic potential. Front Pharmacol. 2026;17:1674533. doi:10.3389/fphar.2026.1674533.

7. Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51. doi:10.1186/s13073-016-0307-y. PMID: 27122046.

8. Umeda N. Gut flora “the second brain” connects Eastern and Western medicine: intestinal hyper-permeability or Qi deficiency can affect brain, mind, and whole body. Longhua Chin Med. 2019;2:5. doi:10.21037/lcm.2019.04.02.

9. Greenfield RH. Dysbiosis, Spleen Qi, Phlegm, and Complex Difficulties. Altern Complement Ther. 2017;23(3):104–109. PMC5512334.

10. Voigt RM, Forsyth CB, Keshavarzian A. Circadian rhythms, the gut microbiome, and metabolic disorders. Gastro Hep Adv. 2024;3(7):993–1000. doi:10.1016/j.gastha.2024.05.011. PMC11307590.

11. Zarrinpar A, Chaix A, Yooseph S, Panda S. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab. 2014;20(6):1006–1017. doi:10.1016/j.cmet.2014.11.008. PMID: 25470548.

12. Zeb F, Wu X, Chen L, et al. Effect of time-restricted feeding on metabolic risk and circadian rhythm associated with gut microbiome in healthy males. Br J Nutr. 2020;123(11):1216–1226. doi:10.1017/S0007114519003428. PMID: 31902372.

13. Ma YY, Hao Z, Chen ZY, et al. Acupuncture and moxibustion for irritable bowel syndrome: an umbrella systematic review. J Integr Med. 2024;22(1):22–31. doi:10.1016/j.joim.2023.12.001. PMID: 38199885.

14. Manheimer E, Cheng K, Wieland LS, et al. Acupuncture for irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2012;107(6):835–847. doi:10.1038/ajg.2012.66. PMID: 22488079.

15. Zhao J, Zheng H, Wang X, et al. Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial. Front Med. 2024;18(4):678–689. doi:10.1007/s11684-024-1073-7.

16. Shen ZY. Pathogenesis of Kidney deficiency syndrome and the HPA axis. Chin J Integr Med. 2005 (review summarizing five decades of work).

17. Hu CC, Liao YH, Lin HY, et al. The effect of hormones of the hypothalamic-pituitary-target gland axes in a Kidney-Yang deficiency syndrome model. World J Tradit Chin Med. 2020;6(4):396–406. doi:10.4103/wjtcm.wjtcm_38_20.

18. Tan Y, Wei Y, Zhang Q, et al. Analysis of gene expression and functional changes of adrenal gland in a rat model of Kidney-Yang deficiency syndrome treated with Sini decoction. Mol Med Rep. 2018;18(4):3993–4004. doi:10.3892/mmr.2018.9410. PMID: 30106157. PMC6125868.

19. Zhang YJ, Zhang LJ, Li JJ, et al. Effect of Hirsutella sinensis fungus on the hypothalamic-pituitary-adrenal axis in Lewis rats with Kidney-Yang deficiency syndrome. Evid Based Complement Alternat Med. 2020;2020:5952612. doi:10.1155/2020/5952612. PMID: 32565866.

20. Liu Y, Yang L, Zhang Y, et al. Global and targeted metabolomics evidences of the protective effect of Chinese patent medicine Jinkui Shenqi pill on adrenal insufficiency after acute glucocorticoid withdrawal in rats. Drug Des Devel Ther. 2017;11:2657–2671. doi:10.2147/DDDT.S141971. PMC5614501.

21. Zhang Y, et al. The pharmacological effects and safety of the raw and prepared folium of Epimedium brevicornu Maxim. on improving Kidney-Yang deficiency syndrome and sexual dysfunction. Front Pharmacol. 2023;14:1233468. doi:10.3389/fphar.2023.1233468.

22. Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol. 2017;13(10):629–646. doi:10.1038/nrneph.2017.107. PMID: 28804120.

23. Leong PK, Wong HS, Chen J, Ko KM. The use of Chinese Yang/Qi-invigorating tonic botanical drugs/herbal formulations in ameliorating chronic kidney disease by enhancing mitochondrial function. Front Pharmacol. 2021;12:622498. doi:10.3389/fphar.2021.622498. PMC8264145.

24. Long Y, et al. One mechanism of spleen-kidney yang deficiency IBS-D: intestinal microbiota affect ATPase. Front Microbiol. 2025;16:1595418. doi:10.3389/fmicb.2025.1595418.

Additional consulted references: Liu R-X, Li Y, Zhang B. Human microbiome brings new insights to traditional Chinese medicine. J Bio-X Res. 2018;1(2):60–67. — Wang H, et al. Shengmai Yin formula modulates the gut microbiota of spleen-deficiency rats. Chin Med. 2020;15:114. doi:10.1186/s13020-020-00394-y. — Su Q, et al. Mitochondrial targeting of herbal medicine in chronic kidney disease. Front Pharmacol. 2021;12:632388. PMC8188236. — Shi Y, Zheng X, et al. Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction. Front Pharmacol. 2022;13:925633. PMC9334908.

Notes on Strength of Evidence

As with most integrative-medicine topics, the strength of evidence varies by claim. The microbial signature of Spleen-deficiency, the HPA-axis correlate of Kidney-Yang deficiency, and the mitochondrial mechanism of Yang-tonifying herbs are now well established in the basic-science literature. The clinical evidence for acupuncture in IBS is moderate and improving; the evidence for individual TCM formulas in human RCTs is more variable. Claims about “leaky gut,” “adrenal fatigue,” and the precise role of food sensitivities remain controversial within mainstream medicine and should be presented to patients with appropriate humility. Integrative practitioners are best served by holding these models as useful clinical heuristics that are increasingly — but not yet uniformly — supported by mechanistic and outcomes data.